US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

ORIC Oric Pharmaceuticals Inc

8.99

0.06 (0.67%)

31 May 2024 - Cerrado

Retrasado por 15 minutos

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Oric Pharmaceuticals (NASDAQ:ORIC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Oric Pharmaceuticals.

Oric Pharmaceuticals (NASDAQ:ORIC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Oric Pharmaceuticals.

Noticias sobre Oric Pharmaceuticals Inc ORIC

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Miércoles 29 de Mayo 2024 (3 días hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 6 de Mayo 2024 (4 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 6 de Mayo 2024 (4 semanas hace) • Edgar (US Regulatory)

ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
Lunes 6 de Mayo 2024 (4 semanas hace) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Viernes 3 de Mayo 2024 (4 semanas hace) • GlobeNewswire Inc.

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
Lunes 15 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Lunes 8 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Viernes 5 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Jueves 4 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Oric Pharmaceuticals Inc Artículos de Noticias

Bluebay Asset Management

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones